Skip to main content
See every side of every news story
Published loading...Updated

Health Canada authorises Abbott's Esprit BTK system for CLTI treatment

Health Canada has granted authorisation for Abbott’s Esprit BTK Everolimus Eluting Resorbable Scaffold System.The post Health Canada authorises Abbott’s Esprit BTK system for CLTI treatment appeared first on Medical Device Network.
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Medical Device Network broke the news in on Tuesday, September 30, 2025.
Sources are mostly out of (0)
News
For You
Search
BlindspotLocal